The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a Phase 2 study in patients with relapsed/refractory B-cell malignancies Meeting Abstract
| Authors: | Hamlin, P. A.; Farber, C. M.; Fenske, T. S.; Khatcheressian, J. L.; Miller, C. B.; Munoz, J.; Patel, M. R.; Schreeder, M. T.; Smith, S. M.; Stevens, D. A.; Pandey, A.; Birrell, M. R.; Leeds, J. M.; Wang, Y. L.; Coffey, G. P.; Curnutte, J. T. |
| Abstract Title: | The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a Phase 2 study in patients with relapsed/refractory B-cell malignancies |
| Meeting Title: | 14th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 14-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-06-07 |
| Start Page: | 74 |
| Language: | English |
| ACCESSION: | 123459768 |
| DOI: | 10.1002/hon.2437_61 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 62 -- Accession Number: 123459768 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
